Search Results - "Cosi, C"
-
1
Biomarkers and clinical predictors of long-term course in obsessivecompulsive disorder: A prospective cohort study
Published in European psychiatry (01-03-2023)“…IntroductionThe purpose of the research project is to analyze the long-term evolution of obsessive-compulsive disorder (OCD) from of a study of a cohort of…”
Get full text
Journal Article -
2
Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist
Published in British journal of pharmacology (01-01-2009)“…Background and purpose: Activation of post‐synaptic 5‐HT1A receptors may provide enhanced therapy against depression. We describe the signal transduction…”
Get full text
Journal Article -
3
Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist
Published in British journal of pharmacology (01-01-2009)“…Background and purpose: Activation of post‐synaptic 5‐HT 1A receptors may provide enhanced therapy against depression. We describe the signal transduction…”
Get full text
Journal Article -
4
F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile
Published in British journal of pharmacology (29-01-2009)“…Background and purpose: Combining 5‐HT 1A receptor activation with dopamine D 2 /D 3 receptor blockade should improve negative symptoms and cognitive deficits…”
Get full text
Journal Article -
5
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia
Published in Neuropharmacology (01-11-2002)“…We report the discovery of F 13640 and evidence suggesting this agent to produce powerful, broad-spectrum analgesia by novel molecular and neuroadaptative…”
Get full text
Journal Article -
6
Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells
Published in Journal of neuroscience research (01-09-1994)“…Glutamate neurotoxicity is correlated with an increase of cytosolic free Ca2+. In some cell systems, activation of Ca2+ dependent endonucleases or formation of…”
Get more information
Journal Article -
7
-
8
c-fos mRNA is spontaneously induced in the rat brain during the activity period of the circadian cycle
Published in The European journal of neuroscience (01-08-1993)“…The basal expression of the proto-oncogene c-fos was studied by Northern blot analysis in different regions of the rat brain during 24 h. A striking…”
Get more information
Journal Article -
9
Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo
Published in Amino acids (01-01-2000)“…Poly(ADP-ribose) polymerase (PARP) is activated in glutamate-induced toxicity of neurons in culture (Cosi et al., 1994). Since injection of the excitatory…”
Get full text
Journal Article -
10
-
11
Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice
Published in Brain research (12-08-1996)“…Treatment of C57Bl/6 mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduced striatal dopamine and cortical noradrenaline levels by 77-83% and…”
Get full text
Journal Article -
12
F17464 a new antipsychotic with preferential D3 antagonist, 5-HT1A partial agonist properties. Neurochemical studies
Published in European psychiatry (01-04-2017)“…F17464 is a new dopamine receptor antagonist that recently demonstrated antipsychotic activity in a proof of concept study in schizophrenic patients under…”
Get full text
Journal Article -
13
-
14
Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice
Published in Brain research (1996)“…Treatment of C57B1/6 mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduced striatal dopamine and cortical noradrenaline levels by 77–83% and…”
Get full text
Journal Article -
15
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
Published in European journal of pharmacology (27-03-2006)“…Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade. We compared the effects of the new antipsychotic…”
Get full text
Journal Article -
16
Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia
Published in The international journal of neuropsychopharmacology (01-09-2005)“…Serotonin 5-HT1A receptors are promising targets in the management of schizophrenia but little information exists about affinity and efficacy of novel…”
Get full text
Journal Article -
17
Role of donor/recipient Na +/H + antiport activity as a nonimmunologic predictor of kidney graft outcome
Published in Transplantation proceedings (01-12-1997)Get full text
Journal Article Conference Proceeding -
18
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo : Role of 5-HT1A receptor activation
Published in Brain research (10-05-2005)“…Excessive activation of non-NMDA receptors, AMPA and kainate, contributes to neuronal degeneration in acute and progressive pathologies, possibly including…”
Get full text
Journal Article -
19
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia
Published in Neuropharmacology (01-11-2002)Get full text
Journal Article -
20
Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells
Published in European journal of pharmacology (14-12-2001)“…Agonist and antagonist properties of antipsychotics at human (h) recombinant 5-hydroxytryptamine (h5-HT(1A)) receptor have been examined previously in…”
Get full text
Journal Article